22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
- With the World Health Organization having declared a Public Health Emergency of International Conc...
Read More >
There is nothing wrong with free unless there is a hidden cost involved. Small business plans that d...
Read More >
On December 19, President Trump signed the Setting Every Community Up for Retirement Enhancement (“...
Read More >
On September 10, 2019, the Appellate Division of the New York Supreme Court for the First Department...
Read More >
Seyfarth Synopsis: The United States Court of Appeals for the Fifth Circuit held that an untimely No...
Read More >
I love Assistant Manager class actions because it gives a defense lawyer a “golden” opportunity to...
Read More >